Gout on the acute medical take. [PDF]
Abhishek A, Cipolletta E.
europepmc +1 more source
Get OUT: Factors Associated With a Longer Length of Stay in Patients Admitted With an Acute Gout Flare, and the Effects of Anakinra on Length of Stay. [PDF]
Weerawardena H +3 more
europepmc +1 more source
Safety, Tolerability, and Efficacy of Shorter Infusion Durations of Pegloticase Administered to Patients With Uncontrolled Gout Receiving Methotrexate: AGILE Trial. [PDF]
Troum OM +6 more
europepmc +1 more source
The efficacy and safety of different doses of febuxostat and allopurinol: A meta-analysis. [PDF]
Zhang F, Wang Y.
europepmc +1 more source
Quzhuo tongbi formula for reducing gout flare related to uric acid lowering treatment: Study protocol for a multiple-center, randomized, double-blind, placebo, parallel-controlled clinical trial. [PDF]
Pan H +15 more
europepmc +1 more source
Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study. [PDF]
Inoue R +5 more
europepmc +1 more source
Antihypertensive drugs for hyperuricemia in patients with hypertension: a systematic review and network meta-analysis of Chinese trials. [PDF]
Wu J, Di H, Zhang Y, Zeng X.
europepmc +1 more source
Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China. [PDF]
Sun J +19 more
europepmc +1 more source
Comparative risk of retinal microvascular disorders in patients with gout initiating febuxostat versus allopurinol: a population-based cohort study. [PDF]
Kim MJ +8 more
europepmc +1 more source

